GlassScriptPhysician profile
Amy L Lee
NPI 1699760751
$3,329.78
in general payments reported to CMS, 2019-2025
13 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $177 · 2021: $417 · 2022: $597 · 2023: $851 · 2024: $432 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,181.47 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $220.64 | 2019-2024 | Apollo Esg System |
| Penumbra, INC. | $148.23 | 2024 | Indigo System |
| Insmed, INC. | $132.61 | 2019 | |
| Alnylam Pharmaceuticals INC. | $125.00 | 2023 | Amvuttra |
| Impulse Dynamics (USA) INC. | $106.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.96 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.49 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $70.66 | 2019 | |
| Pfizer INC. | $52.92 | 2022-2024 | |
| Astellas Pharma US INC | $51.11 | 2025 | Cresemba |
| Abbvie INC. | $28.24 | 2025 | |
| Harrow Eye, LLC | $25.82 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.